FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed is application of known hypnotic zolpiderm in acute period of craniocerebral trauma (CCT) as neuroprotective medication. Described is prophylaxis of secondary complications, indused by craniocerebral trauma, and recovery of neuro-psychic status, as well as recovery of integrative brain functions under zolpiderm action still in acute period of CCT, which determined outcomes of traumatic disease of brain.
EFFECT: elimination of hypoxic and amnestic disorders.
4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICINAL AGENT OFFERING ANTI-ISCHEMIC, ANTIHYPOXIC AND ANTICONVULSANT EFFECT IN CRANIAL TRAUMA | 2005 |
|
RU2309745C2 |
| MEDICATION, PROVIDING NEURO-PROTECTIVE ACTION IN ACUTE PERIOD OF CRANIOCEREBRAL INJURY | 2009 |
|
RU2414901C2 |
| MEDICINAL AGENT SHOWING MULTIFACTOR NEUROPROTECTIVE AND NOOTROPIC EFFECT IN CRANIAL TRAUMA | 2005 |
|
RU2318501C2 |
| ANTICONVULSANT AND ANTIHYPOXIC AGENT | 2008 |
|
RU2393857C2 |
| METHOD FOR TREATMENT OF CEREBROVASCULAR BRAIN DISORDERS (OPTIONS) | 2017 |
|
RU2659674C1 |
| APPLICATION OF BETA-HYDROXYBUTYRATE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR PREPARATION OF MEDICATION WHICH POSSESSES CYTOPROTECTIVE ACTIVITY, INCLUDING NEUROPROTECTIVE, CARDIOPROTECTIVE, ANTI-ISCHEMIC, ANTI-HYPOXIC, ANTI-STRESS, ACTOPROTECTIVE AND ADAPTOGENIC ACTIVITY, MEDICATION AND METHOD OF PREVENTION, RELIEF AND TREATMENT BY MEANS OF SAID MEDICATION | 2009 |
|
RU2426535C2 |
| PHARMACEUTICAL NEUROPROTECTIVE, ANTIOXIDANT, ANTIHYPOXIC, ANTIAPOPTOTIC AND MEMBRANE PROTECTIVE COMPOSITION AND METHOD OF TREATMENT | 2008 |
|
RU2385722C1 |
| METHOD OF TREATING CRANIOCEREBRAL INJURY AND AGENT FOR IMPLEMENTATION THEREOF | 2023 |
|
RU2826364C1 |
| POLYPEPTIDE COMPOSITION HAVING PROPERTY OF NORMALIZING CEREBRAL FUNCTIONS | 2019 |
|
RU2727154C1 |
| POLYPEPTIDE COMPOSITION HAVING PROPERTY OF NORMALIZING CEREBRAL FUNCTIONS | 2019 |
|
RU2726854C1 |
